Sign in
4

Changes in Ownership

KALA BIO, Inc. Filed Acc 0001415889-23-009133

CHIEF EXECUTIVE OFFICER acquired 71,715 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Iwicki Mark T CHIEF EXECUTIVE OFFICER 2023-05-31 Grant or award +71,715 117,681 D
Derivatives
Iwicki Mark T CHIEF EXECUTIVE OFFICER 2023-05-31 Returned to the company · Stock Option (right to buy) −5,449 0 D
Iwicki Mark T CHIEF EXECUTIVE OFFICER 2023-05-31 Returned to the company · Stock Option (right to buy) −7,576 0 D
Iwicki Mark T CHIEF EXECUTIVE OFFICER 2023-05-31 Returned to the company · Stock Option (right to buy) −12,195 0 D
Iwicki Mark T CHIEF EXECUTIVE OFFICER 2023-05-31 Returned to the company · Stock Option (right to buy) −1,572 0 D
Iwicki Mark T CHIEF EXECUTIVE OFFICER 2023-05-31 Returned to the company · Stock Option (right to buy) −4,599 0 D
Iwicki Mark T CHIEF EXECUTIVE OFFICER 2023-05-31 Returned to the company · Stock Option (right to buy) −9,199 0 D
Iwicki Mark T CHIEF EXECUTIVE OFFICER 2023-05-31 Returned to the company · Stock Option (right to buy) −7,299 0 D
Iwicki Mark T CHIEF EXECUTIVE OFFICER 2023-05-31 Returned to the company · Stock Option (right to buy) −6,059 0 D
Iwicki Mark T CHIEF EXECUTIVE OFFICER 2023-05-31 Returned to the company · Stock Option (right to buy) −15,499 0 D
Iwicki Mark T CHIEF EXECUTIVE OFFICER 2023-05-31 Returned to the company · Stock Option (right to buy) −2,268 0 D
Loading xslF345X04/form4-06022023_080601.xml…